|
|
Article: After Redux? Here's how Meridia was introduced into a 'tainted' market. (anti-obesity drugs)
- Article from:
- Medical Marketing & Media
- Article date:
- August 1, 1998
- Author:
CopyrightCOPYRIGHT 1998 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Given the research investment in a new pharmaceutical, preparation for its introduction is an intense, time-consuming task. It is not unusual for the company's marketing team and its advertising agency to work for two or more years on the launch, while the product moves through the final research stages and the FDA approval process. Because of this time frame, the early creative concept (the work that may have won the assignment for the agency) almost never survives the changes which occur in the marketplace and the rethinking of the marketing plan which occurs while the product undergoes FDA clearance. This prolonged developmental period is prone to experimentation with ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA APPROVES NEW OBESITY DRUG `MERIDIA' COMES WITH WARNING ...
Rocky Mountain News (Denver, CO);
November 25, 1997 ;
694 words
... ... the FDA said Monday. But Meridia can cause increases in blood ... pounds.'' But the FDA said Meridia does not appear to pose the ... s most popular diet drugs, Redux and fenfluramine, the ... phen. The agency approved Meridia Saturday night over the objections ...
|
|